LoginSignup
DiaSorin logo

DiaSorin

Stock
Stock
ISIN: IT0003492391
Ticker: DIA
IT0003492391
DIA

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 20.05.2026

$1.043

CHART BY

Frequently asked questions

What is DiaSorin's market capitalization?

The market capitalization of DiaSorin is $3.83B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is DiaSorin's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for DiaSorin is 23.00. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for DiaSorin?

DiaSorin's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.165. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for DiaSorin's stock?

Currently, 15 analysts cover DiaSorin's stock, with a consensus target price of $83.56. Analyst ratings provide insights into the stock's expected performance.

What is DiaSorin's revenue over the trailing twelve months?

Over the trailing twelve months, DiaSorin reported a revenue of $1.38B.

Is DiaSorin paying dividends?

Yes, DiaSorin is paying dividends. The next payment is scheduled for 20.05.2026, with an expected amount of .

What is the free float of DiaSorin's shares?

The free float of DiaSorin is 21.10M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$3.83B
EPS (TTM) 
$3.165
Free Float 
21.10M
P/E ratio (TTM) 
23.00
Revenue (TTM) 
$1.38B

Pricing

1D span
$68.86$71.40
52W span
$60.79$114.82

Analyst Ratings

The price target is $83.56 and the stock is covered by 15 analysts.

Buy

6

Hold

7

Sell

2

Information

DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. It operates through following segments Immunodiagnostics, Molecular Diagnostics, and Life Science. The Immunodiagnostics segment engages in the development of new tests based on complex algorithms. The Molecular Diagnostics segment focuses on providing specialty tests and complex multiplex solutions. The Life Science segment offers diagnostic instruments and technology. The firm provides clinical services in areas like Infectious diseases, bone and mineral, endocrinology, hypertension, oncology, stool diagnostics and autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
IT0003492391
Primary Ticker
DIA

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin